Asalyxa Bio develops targeted therapies that focus on neutrophil modulation to address diseases with significant unmet medical needs, such as autoimmune disorders and chronic inflammatory conditions. By specifically directing treatments to neutrophils, the company aims to improve patient outcomes and reduce the burden of these challenging diseases.

This company provides an AI platform designed to assist enterprise compensation teams with pay decisions using proprietary market data. The platform features AI agents that analyze market trends for compensation analysts and scale expertise for HR and recruiting stakeholders. It integrates with existing HR infrastructure to ensure accurate, real-time compensation alignment with company strategy.

Espervita Therapeutics develops metabolic reprogramming therapies targeting cancers with significant unmet medical need, starting with liver cancer. Their preclinical work shows these novel therapies inhibit cancer cell proliferation and reduce tumor burden. The company focuses on creating effective systemic therapeutics where current treatment options offer limited survival improvement.

Evoq Therapeutics develops disease-specific immune modulators for cancer immunotherapy, targeting the immune system to enhance its response against tumors. Their approach aims to improve patient outcomes by tailoring treatments to individual cancer profiles, addressing the limitations of conventional therapies.

Flightpath offers a flight management system that integrates campaign, sales, and financial data for podcast ad networks and publishers, utilizing predictive analytics to enhance revenue generation. The platform provides real-time insights and forecasting tools to minimize make-goods and optimize inventory management, addressing inefficiencies in ad operations.

HAPPE Spine specializes in enhancing the mechanical properties of PEEK polymer materials for spinal implants, ensuring they meet the rigorous demands of orthopedic procedures. The company provides durable and biocompatible solutions that withstand mechanical stresses, addressing the critical need for reliable materials in medical applications.

Iaso Therapeutics develops next-generation vaccines using a novel virus-like particle technology, mutant Qβ, which enhances antibody generation compared to traditional carrier proteins. This approach addresses the urgent need for effective vaccines against emerging pathogens and diseases, including cancer and infections.

InheRET utilizes an online tool to collect detailed family health histories, enabling individuals to assess their genetic risk for hereditary cancers such as breast and colon cancer. By providing personalized risk reduction strategies, the platform empowers users to take proactive steps in disease prevention, addressing the critical issue of undetected hereditary conditions in millions of people.

M3D provides advanced 3D printing solutions for rapid prototyping and additive manufacturing applications. The company develops high-resolution desktop 3D printers and proprietary materials designed for engineering and design workflows. Their technology enables users to produce functional parts with improved dimensional accuracy and surface finish.

Mark provides a unified commerce platform that integrates physical and digital sales channels, allowing businesses to manage operations, track performance metrics, and engage customers through automated CRM tools. This solution addresses the challenge of fragmented sales processes by centralizing data and streamlining customer interactions, enhancing productivity and decision-making for small and medium enterprises.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

Provides a platform that connects brands with a network of over 2,000 pre-vetted content creators to produce user-generated video ads. By automating script writing, creator casting, and project management, it reduces the time and cost of traditional ad production while delivering high-performing campaigns that drive engagement and sales.

Novo utilizes AI to rapidly draft legal documents such as demand letters and medical chronologies, significantly reducing the time required from days to minutes. By analyzing client records, Novo enables injury attorneys to create high-quality, compelling narratives that enhance settlement outcomes.

This company develops therapeutics designed to enhance and protect microglia, the immune cells of the brain. Their approach utilizes generative AI and biomarker technology to address the declining debris clearance function associated with aging and neurological disease. The core value is improving brain health by restoring microglial function to clear harmful pathogens and cellular debris.

Get Parallel provides a headcount planning solution that integrates with QuickBooks and Xero to automate data synchronization and enhance forecasting accuracy for finance teams. By simplifying scenario planning and delivering clear financial KPIs, the platform reduces manual reconciliation time and supports informed hiring decisions.

PatenSee offers a contactless optical imaging system for monitoring vascular access in dialysis patients, significantly reducing the assessment time from 7-8 minutes to just 1 minute. This technology mitigates the risks of infection and discomfort associated with manual checks while providing objective, data-driven analyses for timely clinical referrals.

Phi, Inc. focuses on enhancing healthspan by utilizing personalized health assessments and data-driven wellness strategies to optimize physical and cognitive function. The platform addresses the challenge of aging by promoting healthier lifestyles that extend both lifespan and quality of life.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

Reset Pharma is developing psilocybin-inspired therapies that aim to reset neural networks in patients facing demoralization due to life-threatening diseases like cancer. By leveraging neuro-biotechnology, the company seeks to enhance the quality of life for terminal patients through targeted mental health interventions.

Ro operates a telehealth platform that provides online clinics for weight loss, sexual health, hair restoration, and fertility management using clinically proven treatments and prescription medications. The service eliminates the need for insurance and offers free, discreet shipping, making healthcare accessible and convenient for over 2 million members.

Tryfi provides a smart dog collar that combines high‑precision GPS tracking with AI‑driven health analytics, delivering real‑time location, activity, and physiological data to the Fi mobile app. Owners receive breed‑specific health insights, step and distance metrics, and instant alerts for abnormal patterns, enabling proactive care and safety monitoring for their pets.

Vert provides a carbon accounting platform that enables businesses to calculate their greenhouse gas emissions, generate detailed reports, and identify reduction strategies. By offering basic functionalities for free and advanced features at a fair price, Vert democratizes access to carbon measurement tools for over 100,000 companies preparing for compliance in the evolving carbon economy.